Trial Profile

A Trial to Evaluate Placebo Microneedle Arrays in Healthy Human Volunteers (Part I), Followed by Proof of Concept Testing of Efficacy and Safety of Doxorubicin Microneedle Arrays in Subjects With Basal Cell Cancer (Part II)

Status: Active, no longer recruiting

Phase of Trial: Phase I/II

Latest Information Update: 17 Apr 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

11 Apr 2023 Number of arms changed from 5 to 2. Placebo Comparator: Placebo-containing MNA, Active Comparator: Doxorubicin-containing MNA - 50 µg and Active Comparator: Doxorubicin-containing MNA - 200 µg arm removed from study protocol.
11 Apr 2023 Planned End Date changed from 31 Dec 2022 to 30 Jun 2024.
11 Apr 2023 Planned primary completion date changed from 30 Sep 2022 to 30 Dec 2023.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com